Bladder Cancer: Assessing & Incorporating Novel Treatment Strategies (CE-eligible)

Description

Bladder Cancer: Assessing and Incorporating Novel Treatment Strategies (0.5 CE; presented by Prime)

Don't miss this webcast, featuring an in-depth look at the latest clinical evidence for bladder cancer treatment and management. Designed with a focus on care in federal, public, and government healthcare settings, experts share practical strategies for integrating novel therapies into treatment decision-making using molecular testing to provide timely access to novel therapies and improve outcomes for patients with bladder cancer.

Expert Faculty:

Bradley A McGregor, MD Planner and Speaker Assistant Professor of Medicine Harvard Medical School Director of Clinical Research Lank Center for Genitourinary Oncology Dana-Farber Cancer Institute Boston, MA

Jennifer Taylor, MD, MPH Speaker Associate Professor, Urology Baylor College of Medicine Dan L Duncan Comprehensive Cancer Center Houston, TX